Status:
COMPLETED
Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Early Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Primary Objective * To investigate and clearly document the presence and extent of cognitive decline, if any, in women of Asian origin following standard-dose systematic adjuvant chemotherapy for the...
Detailed Description
As the survival rate and prognosis of cancer improve, there is increasing recognition of the presence of a long term negative impact of standard chemotherapy on cognition, namely in the domains of att...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically documented breast cancer
- Females greater than 18 years old
- Eastern Cooperative Oncology Group (ECOG) Performance status 0,1,2
- Requires to undergo standard-dose systemic adjuvant chemotherapy
- Patients must be informed of nature of study and sign an informed consent form
- Exclusion criteria
- a. Dementia/significantly altered mental status that will prohibit the understanding and/or giving of informed consent
Exclusion
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00713141
Start Date
November 1 2004
Last Update
August 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore